Search for: "Astrazeneca"
Results 281 - 300
of 1,244
Sort by Relevance
|
Sort by Date
10 Aug 2017, 3:41 pm
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday SurprisesNever Too Late 154 [week ending Sunday 2 July] I Book Review: Patent Drawing… [read post]
8 Aug 2017, 12:10 pm
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday Surprises Never Too Late 154 [week ending Sunday 2 July] I Book Review: Patent… [read post]
23 Jul 2017, 4:00 am
Pharmaceutical Patents: “Promise of the Patent” Doctrine re Utility AstraZeneca Canada Inc. v. [read post]
21 Jul 2017, 3:14 am
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday SurprisesNever Too Late 154 [week ending Sunday 2 July] I Book Review: Patent… [read post]
20 Jul 2017, 7:44 am
Onglyza was co-developed by Bristol-Meyers Squibb and AstraZeneca and is a DPP-4 inhibitor. [read post]
15 Jul 2017, 5:11 am
The Court dismisses Actavis' cross-appeal on the basis that if its products did not directly infringe, they would indirectly infringe to the extent held by the Court of Appeal.And, of course, the weekly updates Monday Miscellany and Sunday Surprises.Photo credit: rawdonfoxPREVIOUSLY ON NEVER TOO LATENever Too Late 154 [week ending Sunday 2 July] I Book Review: Patent Drawing Rules I German Supreme Court holds that extra-territorial delivery can result in patent infringement I Canadian… [read post]
9 Jul 2017, 3:15 am
Cooperstock, 2017 FC 616 https://t.co/ZNHOe0Brjg -> Good case for establishing criteria for collateral contracts Innotech Aviation v Skylink Express 2017 NSSC 176 https://t.co/rcZj2pOks4 -> Link to Supreme Court case abolishing the promise doctrine in Canada AstraZeneca Canada v Apotex Inc. 2017 SCC 36 https://t.co/5CMCa5ys0J -> NDP MP apologizes for plagiarizing parts of an op-ed column https://t.co/LYSf14x0ce -> Feds to widen scope of $1.26B business innovation fund to cover… [read post]
9 Jul 2017, 1:11 am
One further step in that direction was taken by the Canadian Supreme Court on 30 June 2017, when it banished the so-called ‘Promise Doctrine’ of inutility from Canadian patent law: AstraZeneca Canada Inc v Apotex Inc 2017 SCC 36. [read post]
6 Jul 2017, 9:30 pm
AstraZeneca Plc, the appellant in the case, reportedly argued that the doctrine made it too easy for drug companies to lose patents. [read post]
6 Jul 2017, 8:21 am
The Supreme Court of Canada issued a ruling in AstraZeneca Canada Inc. v. [read post]
6 Jul 2017, 3:15 am
Cooperstock, 2017 FC 616 https://t.co/ZNHOe0Brjg -> Good case for establishing criteria for collateral contracts Innotech Aviation v Skylink Express 2017 NSSC 176 https://t.co/rcZj2pOks4 -> Link to Supreme Court case abolishing the promise doctrine in Canada AstraZeneca Canada v Apotex Inc. 2017 SCC 36 https://t.co/5CMCa5ys0J -> NDP MP apologizes for plagiarizing parts of an op-ed column https://t.co/LYSf14x0ce -> Feds to widen scope of $1.26B business innovation fund to cover… [read post]
5 Jul 2017, 11:34 am
Canadian Supreme Court holds promise doctrine "unsound" in AstraZeneca v Apotex Nexium disputeThe AmeriKat Annsley provides a timely and in-depth analysis on the much-awaited decision rendered by the Supreme Court of Canada in the appeal between AstraZeneca Canada v Apotex (2017 SCC 36). [read post]
2 Jul 2017, 8:30 pm
Don MacOdrum, Don Cameron, Micheline Gravelle, and Michael Fenwick will provide a point-by-point analysis of the greatly anticipated decision of the Supreme Court of Canada in AstraZeneca v. [read post]
2 Jul 2017, 12:52 am
AstraZeneca brought an action for patent infringement against Apotex. [read post]
1 Jul 2017, 9:39 am
AstraZeneca brought an action for patent infringement against Apotex. [read post]
30 Jun 2017, 6:18 am
In its decision, the Board of Appeal has also explicitly emphasized that the above finding will align the duration of Italian SPCs with the principles established in the CJEU case law, specifically in the Novartis and others judgment and AstraZeneca order.With this decision, it thus appears that Italy is now part of the EU countries that allow for the administrative “correction” of the expiry date of granted SPCs, even if only when such “correction”… [read post]
30 Jun 2017, 6:18 am
In its decision, the Board of Appeal has also explicitly emphasized that the above finding will align the duration of Italian SPCs with the principles established in the CJEU case law, specifically in the Novartis and others judgment and AstraZeneca order.With this decision, it thus appears that Italy is now part of the EU countries that allow for the administrative “correction” of the expiry date of granted SPCs, even if only when such “correction”… [read post]
12 May 2017, 9:05 am
., AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca PLC, and AstraZeneca AB (collectively, Bristol-Myers/AstraZeneca), which developed, manufactured, and marketed the drugs, failed to adequately test the drugs and warn of their risks. [read post]
6 May 2017, 10:11 am
The decision Braintree v. [read post]
4 May 2017, 6:55 am
Astrazeneca Pharmaceutical, LP, May 2, 2017, Thompson, O.). [read post]
